Research output per year
Research output per year
Personal profile
Research interests
Onderzoeksbelangen
External positions
Hoogleraar Klinische Farmacologie, Universiteit Utrecht
1 Jul 2016 → …
Ziekenhuisapotheker, Nederlands Kanker Instituut
1 Oct 2003 → …
Fingerprint
Dive into the research topics where Alwin Huitema is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
High-dose individualized antithymocyte globulin with therapeutic drug monitoring in high-risk cord blood transplant
Admiraal, R., Versluijs, A. B., Huitema, A. D. R., Ebskamp, L., Lacna, A., de Kanter, C. T. K., Bierings, M. B., Boelens, J. J., Lindemans, C. A. & Nierkens, S., Jan 2024, In: Cytotherapy. 26, 6, p. 599-605 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
IKZF1 gene deletions drive resistance to cytarabine in B-cell precursor acute lymphoblastic leukemia
Vervoort, B. M. T., Butler, M., Grünewald, K. J. T., Schenau, D. S. V. I., Tee, T. M., Lucas, L., Huitema, A. D. R., Boer, J. M., Bornhauser, B. C., Bourquin, J.-P., Hoogerbrugge, P. M., Van der Velden, V. H. J., Kuiper, R. P., Van der Meer, L. T. & Van Leeuwen, F. N., Jun 2024, In: Haematologica.Research output: Contribution to journal › Article › peer-review
-
Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015)
Rubio-San-Simón, A., van Eijkelenburg, N. K. A., Hoogendijk, R., Hasle, H., Niemeyer, C. M., Dworzak, M. N., Zecca, M., Lopez-Yurda, M., Janssen, J. M., Huitema, A. D. R., van den Heuvel-Eibrink, M. M., Laille, E. J., van Tinteren, H. & Zwaan, C. M., 2023, In: Paediatric drugs. 25, 6, p. 719-728 10 p.Research output: Contribution to journal › Article › peer-review
-
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921
Brivio, E., Pennesi, E., Willemse, M. E., Huitema, A. D. R., Jiang, Y., van Tinteren, H. D. R., van der Velden, V. H. J., Beverloo, B. H., den Boer, M. L., Rammeloo, L. A. J., Hudson, C., Heerema, N., Kowalski, K., Zhao, H., Kuttschreuter, L., Bautista Sirvent, F. J., Bukowinski, A., Rizzari, C., Pollard, J. & Murillo-Sanjuán, L. & 16 others, , 30 Nov 2023, (E-pub ahead of print) In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. p. JCO2300897Research output: Contribution to journal › Article › peer-review
Open Access -
Radiosensitisation by olaparib through focused ultrasound delivery in a diffuse midline glioma model
't Hart, E., Bianco, J., Bruin, M. A. C., Derieppe, M., Besse, H. C., Berkhout, K., Chin Joe Kie, L. A., Su, Y., Hoving, E. W., Huitema, A. D. R., Ries, M. G. & van Vuurden, D. G., May 2023, In: Journal of Controlled Release. 357, p. 287-298 12 p.Research output: Contribution to journal › Article › peer-review
Open Access